# OnCo record eortc-22863 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eortc-22863/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eortc-22863", "NCT00849082" ;
  schema:name "EORTC 22863"@en ;
  schema:alternateName "EORTC 22863"@en, "Bolla trial"@en ;
  schema:description "The trial that proved hormone therapy should be added to radiotherapy for aggressive prostate cancer, and that the addition roughly halves the chance of dying of it."@en ;
  schema:url <https://onco.cc/trials/eortc-22863/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00849082>, <https://doi.org/10.1016/S1470-2045(10)70223-0> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/goserelin/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:terms <https://onco.cc/terms/adt/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/terms/hormone-therapy/> ;
  onco:trials <https://onco.cc/trials/eortc-22961/>, <https://onco.cc/trials/rtog-9202/>, <https://onco.cc/trials/spcg-7/> .